GUFIC BIOSCIENCES LTD. SHARE PRICE [LIVE]
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Dec 22 | Sep 22 |
|---|---|---|
| Promoters (Change:0.00) | 75% | 75% |
| FIIs (Change:0.10) | 0.16% | 0.06% |
| Mutual Funds (Change:-0.00) | 1.03% | 1.03% |
| Insurance Companies (Change:0.00) | 0% | 0% |
| Other DIIs (Change:-0.01) | 0.12% | 0.13% |
| Non Institution (Change:-0.09) | 23.69% | 23.78% |
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in GUFIC BIOSCIENCES LTD.
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
GUFICBIO News
Frequently Asked Questions
What is the Share price of GUFIC BIOSCIENCES LTD. (GUFICBIO)?
Can I buy GUFIC BIOSCIENCES LTD. (GUFICBIO) shares?
How do I buy GUFIC BIOSCIENCES LTD. (GUFICBIO) from Angel One?
- Direct investment: You can buy GUFIC BIOSCIENCES LTD. (GUFICBIO) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to GUFIC BIOSCIENCES LTD. (GUFICBIO) shares.
In which sector do GUFIC BIOSCIENCES LTD. (GUFICBIO) belong?
About GUFICBIO
Today's live share price for GUFIC BIOSCIENCES LTD. is NSE: ₹ 188.05, BSE: ₹ 188.90 with a current market capitalization of .
Gufic Biosciences (GBL) is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. The Choksi and Gandhi family, the promoters of GBL, have a long-standing presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil. In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held. Gufic has divested brands in the ethical pharma business in a seller's market. The company plan to invest further in R&D activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.
Read more
